Zurich \u2014 Syz Capi\u00adtal, the private markets invest\u00adment boutique, today announ\u00adced the acqui\u00adsi\u00adtion of a majo\u00adrity stake in SK Pharma Logi\u00adstics, a provi\u00adder specia\u00adli\u00adzing in the storage, hand\u00adling, repack\u00ada\u00adging and distri\u00adbu\u00adtion of phar\u00admaceu\u00adti\u00adcal products. With the support of the Syz family and in close part\u00adner\u00adship with Satur\u00adnus Capi\u00adtal, Syz Capi\u00adtal aims to drive the growth of this strong market leader and acce\u00adle\u00adrate its expan\u00adsion to ensure the company conti\u00adnues to soar.<\/p>\n
SK Pharma is a family-run company based in Biele\u00adfeld, Germany, provi\u00adding services to phar\u00admaceu\u00adti\u00adcal compa\u00adnies in Europe and world\u00adwide. The indus\u00adtry leader specia\u00adli\u00adzes in phar\u00admaceu\u00adti\u00adcal, medi\u00adcal, cosme\u00adtic and dietary products. The company\u2019s offe\u00adring covers the entire logi\u00adstics value chain and provi\u00addes complete solu\u00adti\u00adons for customers.<\/p>\n
With a compound annual growth rate (CAGR) of 28% over the last three years, the company can look back on remar\u00adkable growth that exceeds that of the German health\u00adcare indus\u00adtry over the last ten years by a factor of seven. The company expects further growth as the regu\u00adla\u00adtory envi\u00adron\u00adment beco\u00admes more strin\u00adgent and the indus\u00adtry as a whole is expec\u00adted to grow steadily over the next few years.<\/p>\n
Marc Syz, Mana\u00adging Part\u00adner of Syz Capi\u00adtal (photo)<\/strong>, says: \u201cWe believe this is a unique oppor\u00adtu\u00adnity to help the family busi\u00adness expand its busi\u00adness and foot\u00adprint, both through orga\u00adnic growth and acqui\u00adsi\u00adti\u00adons, and thus conso\u00adli\u00addate the rela\u00adtively frag\u00admen\u00adted sector serving inter\u00adna\u00adtio\u00adnal custo\u00admers. With SK Pharma, we have indeed found another niche leader, a so-called \u201chidden cham\u00adpion\u201d, which offers a strong plat\u00adform for future value creation.<\/p>\n The deal also illus\u00adtra\u00adtes the value crea\u00adtion poten\u00adtial for our clients\u2019 port\u00adfo\u00adlios and how Syz Capi\u00adtal is unlo\u00adcking unique synergy oppor\u00adtu\u00adni\u00adties in private equity and alter\u00adna\u00adtive investments.\u201d<\/p>\n Syz Capi\u00adtal is an invest\u00adment boutique specia\u00adli\u00adzing in private markets, offe\u00adring exclu\u00adsive access to niche private equity and alter\u00adna\u00adtive investments.<\/p>\n Joscha Boehm, Mana\u00adging Part\u00adner of Satur\u00adnus Capi\u00adtal<\/strong> and Phil\u00adipp Schwei\u00adzer, Part\u00adner at Satur\u00adnus Capi\u00adtal, who execu\u00adted this tran\u00adsac\u00adtion toge\u00adther with Syz Capi\u00adtal, commen\u00adted, \u201cWe look forward to working closely with the foun\u00adders and the manage\u00adment team to further deve\u00adlop SK Pharma in the coming years. We believe SK Pharma is extre\u00admely well posi\u00adtio\u00adned as a well-mana\u00adged company to conti\u00adnue to grow and gain market share.\u201d Satur\u00adnus Capi\u00adtal is a private equity firm focu\u00adsing on mid-market tran\u00adsac\u00adtions in the DACH region.<\/p>\n The acqui\u00adsi\u00adtion repres\u00adents another important mile\u00adstone for Syz Capi\u00adtal in the family busi\u00adness sector. Both Satur\u00adnus and Marc Syz will join SK Phar\u00adma\u2019s board, which includes the Krone family and Phil\u00adippe Milliet, a former member of Gale\u00adni\u00adca\u2019s execu\u00adtive commit\u00adtee and vete\u00adran indus\u00adtry veteran.<\/p>\n Stephan Krone, CEO of SK Pharma Logi\u00adstics GmbH, added: \u201cIn our view, Syz Capi\u00adtal and Satur\u00adnus Capi\u00adtal, with their exten\u00adsive expe\u00adri\u00adence in inves\u00adt\u00ading in family busi\u00adnesses, are the ideal part\u00adners to guide SK Pharma through its next growth phase and beyond, crea\u00adting value for our custo\u00admers and part\u00adners. They have a clear growth stra\u00adtegy for the future. The manage\u00adment team and myself are looking forward to the part\u00adner\u00adship and to buil\u00adding SK Pharma into a major Euro\u00adpean player in the logi\u00adstics sector for the phar\u00admaceu\u00adti\u00adcal industry.\u201d<\/p>\n About the Syz Group<\/strong><\/p>\n Syz Group is a family-owned Swiss finan\u00adcial group that focu\u00adses on good long-term invest\u00adment perfor\u00admance, robust risk manage\u00adment and perso\u00adna\u00adli\u00adzed custo\u00admer service. In a family of entre\u00adpre\u00adneurs that has been successful for centu\u00adries, the company was co-foun\u00added in 1996 by Eric Syz, who now runs it with his two sons and a team of indus\u00adtry experts. Stable and secure \u2014 the Syz Group\u2019s equity capi\u00adta\u00adliza\u00adtion is almost double the regu\u00adla\u00adtory requi\u00adre\u00adment in Switzerland.<\/p>\n","protected":false},"excerpt":{"rendered":" Zurich \u2014 Syz Capi\u00adtal, the private markets invest\u00adment boutique, today announ\u00adced the acqui\u00adsi\u00adtion of a majo\u00adrity stake in SK Pharma Logi\u00adstics, a provi\u00adder specia\u00adli\u00adzing in the storage, hand\u00adling, repack\u00ada\u00adging and distri\u00adbu\u00adtion of phar\u00admaceu\u00adti\u00adcal products. With the support of the Syz family and in close part\u00adner\u00adship with Satur\u00adnus Capi\u00adtal, Syz Capi\u00adtal aims to drive the growth [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":39446,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1365,1366,1369,1375],"tags":[],"class_list":["post-40131","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-private-equity-en","category-news-en","category-investors","category-family-offices-en"],"yoast_head":"\n